Recruiting

Prevalence and Severity of Depression in Coronary Artery Disease Patients

ClinicalTrials.gov IDNCT06740396

PhaseNot Applicable

Enrollment200

SponsorAl-Nahrain University

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Depression - Major Depressive Disorder

About this study

This observational study aims to estimate the prevalence and severity of depression among patients with coronary artery disease (CAD) in Baghdad, Iraq, using the self-administered PHQ-9 questionnaire. The study seeks to answer the following questions: What is the prevalence of depression among CAD patients? How is the severity of depression distributed within this group? Are specific demographic, clinical, or environmental factors associated with higher levels of depression? Participants will: Complete the PHQ-9 to assess the severity of depressive symptoms at a specific point in time. Provide demographic and clinical information, including age, gender, socioeconomic status, comorbidities, and CAD-related factors such as type of intervention and duration of illness, to explore potential correlations with depression.

Primary outcomes

Prevalence of Depression (Data collection will occur over a 3-month period, with each participant completing the assessment at a single point during this time frame.)
Severity of Depression (Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.)
Patient Health Questionnaire-9 (PHQ-9) (Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.)

Eligibility information

Inclusion Criteria: * Diagnosed with coronary artery disease (confirmed through clinical, imaging, or procedural evidence). * Receiving care at designated hospitals in Baghdad. * Able to understand and complete the PHQ-9 questionnaire independently or with minimal assistance. * Consents to participate in the study. Exclusion Criteria: * Patients with a history of severe psychiatric disorders unrelated to depression (e.g., schizophrenia, bipolar disorder). * Patients with cognitive impairments or neurological conditions affecting their ability to complete the questionnaire. * Those currently hospitalized for acute cardiac events (e.g., myocardial infarction) requiring intensive care. * Individuals unwilling to provide informed consent.

Study locations

College of Medicine - Al-Nahrain University, Baghdad, Iraq

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.